Skip to main content

The impact of centrifugation in primary care on pseudohyperkalaemia: a retrospective evaluation.

Turner HE, Peake RW, Allison JJ

Publication: Ann Clin Biochem (2013) • Vol 50 • Page 371-3PMID: 23761382View on PubMed

Purpose

The purpose of this paper was to determine the effects of centrifugation before or after transport to the lab on measurement of potassium in serum.

Conclusion

Implementation of on-site blood centrifugation significantly decreased the number of specimens classified as hyperkalaemic and increased the number classified as normokalaemic without affecting the number of specimens classified as hypokalaemic.

Studies (1)

Purpose

The purpose of this study was to determine the impact of on-site centrifugation on the measurement of potassium in serum. No details of specimen collection or transport were included. Prior to implementation of on site centrifugation, <20% of specimens were centrifuged on-site, and after implementation, >95% of specimens were centrifuged on-site.

Summary of Findings

After implementation of on-site blood centrifugation, the number of serum specimens characterized as having marked hyperkalaemia (>6.0 mmol/L potassium) and moderate hyperkalaemia (5.3-6.0 mmol/L potassium) decreased from 1.7% and 5.5% of the 131,364 specimens, respectively, when specimens were centrifuged after transport to 0.4% and 2.8% of the 140,481 specimens, respectively (p<0.0001, both). Only one of the cases of moderate hyperkalaemia identified prior to on-site centrifugation was confirmed by repeat testing, but the authors do not report how many specimens were subjected to retest. Further, after implementation of on-site centrifugation, the number of normokalaemic specimens (3.5-5.2 mmol/L potassium) increased from 91% in specimens centrifuged after transport to 95% (p<0.001), but the number of hypokalaemic specimens was comparable before and after the implementation. Importantly, implementation of on-site centrifugation reduced the number of patients admitted to the hospital based on pseudohyperkalaemia from 8 to 0.

  • Biospecimens

    FluidBlood
    FluidSerum
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    Electrolyte/MetalClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    3.5-5.2 mmol/L potassium
    5.3-6.0 mmol/L potassium
    <3.5 mmol/L potassium
    >6.0 mmol/L potassium
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageSpecimen transport duration/condition
    Centrifuged
    Not centrifuged
    StorageStorage duration
    0 min
    Unspecified storage duration